Adjuvant activity of Escherichia coli heat-labile enterotoxin and effect on the induction of oral tolerance in mice to unrelated protein antigens
- PMID: 3048010
- DOI: 10.1016/0264-410x(88)90223-x
Adjuvant activity of Escherichia coli heat-labile enterotoxin and effect on the induction of oral tolerance in mice to unrelated protein antigens
Abstract
The ability of Escherichia coli heat-labile enterotoxin (LT) to influence the induction and maintenance of tolerance was examined in animals primed orally with a soluble protein antigen, ovalbumin (OVA), or in animals primed orally with two unrelated protein antigens administered simultaneously, OVA and bovine serum albumin (BSA). LT is immunologically and structurally related to the cholera enterotoxin (CT), which has been shown to be capable of abrogating oral tolerance to protein antigens when delivered simultaneously with the antigens. In this study, simultaneous administration of LT with OVA was shown to prevent the induction of tolerance to OVA and to increase the serum anti-OVA IgG response 30- to 90-fold over OVA-primed and PBS-primed animals, respectively. This effect was determined to be a function of the enzymatically active A subunit of the toxin since the B (binding) subunit alone was unable to influence tolerance induction. Animals fed LT with OVA after the initial OVA prime developed a significantly lower serum IgG and mucosal IgA anti-OVA response than those fed LT with OVA in the initial immunization, indicating that prior exposure to the antigen reduces the effectiveness of LT to influence tolerance and its ability to act as an adjuvant. LT was not able to abrogate tolerance once it had been established. Serum IgG and mucosal IgA responses in animals receiving LT on only a single occasion, that being upon first exposure to antigen, were equivalent to responses after three OVA/LT primes, indicating that commitment to responsiveness occurs early and upon first exposure to antigen.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity.Infect Immun. 1995 May;63(5):1617-23. doi: 10.1128/iai.63.5.1617-1623.1995. Infect Immun. 1995. PMID: 7729864 Free PMC article.
-
Gut flora allows recovery of oral tolerance to ovalbumin in mice after transient breakdown mediated by cholera toxin or Escherichia coli heat-labile enterotoxin.Pediatr Res. 1996 Apr;39(4 Pt 1):625-9. doi: 10.1203/00006450-199604000-00011. Pediatr Res. 1996. PMID: 8848336
-
Mucosal immunoadjuvant activity of recombinant Escherichia coli heat-labile enterotoxin and its B subunit: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with influenza virus surface antigen.Vaccine. 1998 Dec;16(20):2069-76. doi: 10.1016/s0264-410x(98)00076-0. Vaccine. 1998. PMID: 9796066
-
The role of ADP-ribosylation and G(M1)-binding activity in the mucosal immunogenicity and adjuvanticity of the Escherichia coli heat-labile enterotoxin and Vibrio cholerae cholera toxin.Immunol Cell Biol. 1998 Jun;76(3):270-9. doi: 10.1046/j.1440-1711.1998.00745.x. Immunol Cell Biol. 1998. PMID: 9682971 Review.
-
A proposal for safety standards for human use of cholera toxin (or Escherichia coli heat-labile enterotoxin) derivatives as an adjuvant of nasal inactivated influenza vaccine.Jpn J Infect Dis. 2000 Jun;53(3):98-106. Jpn J Infect Dis. 2000. PMID: 10957706 Review.
Cited by
-
Enterotoxin-based mucosal adjuvants alter antigen trafficking and induce inflammatory responses in the nasal tract.Infect Immun. 2005 Oct;73(10):6892-902. doi: 10.1128/IAI.73.10.6892-6902.2005. Infect Immun. 2005. PMID: 16177369 Free PMC article.
-
Effect of multiple antigenic exposures in the gut on oral tolerance and induction of antibacterial systemic immunity.Infect Immun. 1999 Nov;67(11):5917-24. doi: 10.1128/IAI.67.11.5917-5924.1999. Infect Immun. 1999. PMID: 10531248 Free PMC article.
-
Distinct cytokine regulation by cholera toxin and type II heat-labile toxins involves differential regulation of CD40 ligand on CD4(+) T cells.Infect Immun. 2001 Jul;69(7):4486-92. doi: 10.1128/IAI.69.7.4486-4492.2001. Infect Immun. 2001. PMID: 11401990 Free PMC article.
-
From allergen to oral vaccine carrier: A new face of ragweed pollen.Int J Pharm. 2018 Jul 10;545(1-2):286-294. doi: 10.1016/j.ijpharm.2018.05.003. Epub 2018 May 3. Int J Pharm. 2018. PMID: 29729407 Free PMC article.
-
Chemically Synthesized Alcaligenes Lipid A Shows a Potent and Safe Nasal Vaccine Adjuvant Activity for the Induction of Streptococcus pneumoniae-Specific IgA and Th17 Mediated Protective Immunity.Microorganisms. 2020 Jul 23;8(8):1102. doi: 10.3390/microorganisms8081102. Microorganisms. 2020. PMID: 32718009 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous